Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53

Molecular and Cellular Biology

Volumn 24, Issue 13, 2004, Pages 5677-5686

  Hui, Li ^a   Abbas, Tarek ^a   Pielak, Rafal M ^a   Joseph, Troy ^a   Bargonetti, Jill ^a   Foster, David A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53; TARGET OF RAPAMYCIN KINASE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION; SURVIVAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DNA DAMAGE; HALF-LIFE; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; PHOSPHOLIPASE D; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 2942716838     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.13.5677-5686.2004     Document Type: Article

References (51)

1. Ahn, B.-H., S. Y. Kim, E. H. Kim, K. S. Choi, T. K. Kwon, Y. H. Lee, J.-S. Chang, M.-S. Kim, Y.-H. Jo, and D. S. Min. 2003. Transmodulation between phospholipase D and c-Src enhances cell proliferation. Mol. Cell. Biol. 23:3103-3115.
2. Banno, Y., Y. Takuwa, Y. Akao, H. Okamoto, Y. Osawa, T. Naganawa, S. Nakashima, P. G. Suh, and Y. Nozawa. 2001. Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3. J. Biol. Chem. 276:35622-35628.
3. Banno, Y., Y. Takuwa, M. Yamada, N. Takuwa, K. Ohguchi, A. Hara, and Y. Nozawa. 2003. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells. Biochem. J. 369:363-368.
4. Bargonetti, J., J. J. Manfredi, X. Chen, D. R. Marshak, and C. Prives. 1993. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7:2565-2574.
5. Biscardi, J. S., D. A. Tice, and S. J. Parsons. 1999. c-Src, receptor tyrosine kinases, and human cancer. Adv. Cancer Res. 76:61-119.
6. Chen, J., and Y. Fang. 2002. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. Biochem. Pharmacol. 64:1071-1077.
7. Chen, Y., Y. Zheng, and D. A. Foster. 2003. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 22:3937-3942.
8. Chene, P. 2003. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 3:102-109.
9. Colley, W. C., T. C. Sung, R. Roll, J. Jenco, S. M. Hammond, Y. Altshuller, D. Bar-Sagi, A. J. Morris, and M. A. Frohman. 1997. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7:191-261.
10. Exton, J. H. 2000. Phospholipase D. Ann. N. Y. Acad. Sci. 905:61-68.
11. Fang, Y., M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen. 2001. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942-1945.
12. Fei, P., and W. S. El-Deiry. 2003. P53 and radiation responses. Oncogene 22:5774-5783.
13. Foster, D. A., and L. Xu. 2003. Phospholipase D in cell proliferation and cancer. Mol. Cancer Res. 1:789-400.
14. Frankel, P. A., M. Ramos, J. Flom, S. Bychenok, E. Kerkhoff, U. R. Rapp, L. A. Feig, and D. A. Foster. 1999. Ral and Rho dependent activation of phospholipase D in v-Raf transformed cells. Biochem. Biophys. Res. Commun. 255:502-507.
15. Ghosh, S., J. C. Strum, V. A. Sciorra, L. Daniel, and R. M. Bell. 1996. Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells. J. Biol. Chem. 271:8472-8480.
16. Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-468.
17. Hammond, S. M., Y. M. Altshuller, T. C. Sung, S. A. Rudge, K. Ross, J. Engebrecht, A. J. Morris, and M. A. Frohman. 1995. Human ARF-activated phosphatidylcholine-specific phospholipase D defines a new highly conserved gene family. J. Biol. Chem. 270:29640-29643.
18. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
19. Hornia, A., Z. Lu, T. Sukezane, M. Zhong, and D. A. Foster. 1999. Antagonistic effects of protein kinase C α and δ on both transformation and phospholipase D activity mediated by the EGF receptor. Mol. Cell. Biol. 19:7672-7680.
20. Iliakis, G., Y. Wang, J. Guan, and H. Wang. 2003. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22:5834-5847.
21. Jiang, H., Z. Lu, J.-Q. Luo, A. Wolfman, and D. A. Foster. 1995. Ras mediates the activation of phospholipase D by v-Src. J. Biol. Chem. 270:6006-6009.
22. Jiang, H., J.-Q. Luo, T. Urano, Z. Lu, D. A. Foster, and L. A. Feig. 1995. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378:409-412.
23. Jiang, Y.-W., J. Song, Q. Zang, and D. A. Foster. 1994. Phosphatidylcholine-specific phospholipase D activity is elevated in v-Fps-transformed cells. Biochem. Biophys. Res. Commun. 203:1195-1203.
24. Joseph, T., R. Wooden, A. Bryant, M. Zhong, Z. Lu, and D. A. Foster. 2001. Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. Biochem. Biophys. Res. Commun. 289:1019-1024.
25. Joseph, T., A. Bryant, R. Wooden, E. Kerkhoff, U. R. Rapp, and D. A. Foster. 2002. Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene 21:3651-3658.
26. Karnam, P., M. L. Standaert, L. Galloway, and R. V. Farese. 1997. Activation and translocation of Rho and ADP ribosylation factor by insulin in rat adipocytes. Apparent involvement of phosphatidylinositol 3-kinase. J. Biol. Chem. 272:6136-6140.
27. Kim, K.-O., K.-H. Lee, Y.-H. Kim, S.-K. Park, and J.-S. Han. 2003. Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death. Exp. Mol. Med. 35:38-45.
28. Kranenburg, O., I. Verlaan, and W. H. Moolenaar. 1999. Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase. J. Biol. Chem. 274:3501-3504.
29. Lu, Z., A. Hornia, T. Joseph, T. Sukezane, P. Frankel, M. Zhong, S. Bychenok, L. Xu, L. A. Feig, and D. A. Foster. 2000. Phospholipase D and Rala cooperate with the EGF receptor to transform 3Y1 rat fibroblasts. Mol. Cell. Biol. 20:462-467.
30. Michael, D., and M. Oren. 2003. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 13:49-58.
31. Min, D. S., T. K. Kwon, W. S. Park, J. S. Chang, S. K. Park, B. H. Ahn, Z. Y. Ryoo, Y. H. Lee, Y. S. Lee, D. J. Rhie, S. H. Yoon, S. J. Hahn, M. S. Kim, and Y. H. Jo. 2001. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 22:1641-1647.
32. Motoike, T., S. Bieger, H. Wiegandt, and K. Unsicker. 1993. Induction of phosphatidic acid by fibroblast growth factor in cultured baby hamster kidney fibroblasts. FEBS Lett. 332:164-168.
33. Noh, D. Y., S. J. Ahn, R. A. Lee, I. A. Park, J. H. Kim, P. G. Suh, S. H. Ryu, K. H. Lee, and J. S. Han. 2000. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 161:207-214.
34. Nozawa, Y. 2002. Roles of phospholipase D in apoptosis and pro-survival. Biochim. Biophys. Acta 1585:77-86.
35. Pipas, J. M., and A. J. Levine. 2001. Role of T antigen interactions with p53 in tumorigenesis. Semin. Cancer Biol. 11:23-30.
36. Plevin, R., S. G. Cook, S. Palmer, and M. J. O. Wakelam. 1991. Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth factor-stimulated Swiss 3T3 fibroblasts. Biochem. J. 279:559-565.
37. ARF. Cell 103:321-330.
38. Rizzo, M. A., K. Shome, C. Vasudevan, D. B. Stolz, T. C. Sung, M. A. Frohman, S. C. Watkins, and G. Romero. 1999. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 274:1131-1139.
39. Schmelzie, T., and M. N. Hall. 2000. TOR, a central controller of cell growth. Cell 103:253-262.
40. Shen, A. Y., L. Xu, and D. A. Foster. 2001. A role for phospholipase D in receptor-mediated endocytosis. Mol. Cell. Biol. 21:595-602.
41. Song, J., L. M. Pfeffer, and D. A. Foster. 1991. v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine. Mol. Cell. Biol. 11:4903-4908.
42. Song, J., Y. W. Jiang, and D. A. Foster. 1994. EGF induces the production of biologically distinguishable diglyceride species from phosphatidylinositol and phosphatidylcholine: evidence for the independent activation of type C and type D phospholipases. Cell Growth Differ. 5:79-85.
43. Uchida, N., S. Okamura, and Y. Nagamachi. 1997. Increased phospholipase D activity in human breast cancer. J. Cancer Res. Clin. Oncol. 123:280-285.
44. Uchida, N., S. Okamura, and H. Kuwano. 1999. Phospholipase D activity in human gastric carcinoma. Anticancer Res. 19:671-676.
45. Vieira, A. V., C. Lamaze, and S. L. Schmid. 1996. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274:2086-2089.
46. Vivanco, I., and C. L. Sawyers. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489-501.
47. Yamada, Y., N. Hamajima, T. Kato, H. Iwata, Y. Yamamura, M. Shinoda, M. Suyama, T. Mitsudomi, K. Tajima, S. Kusakabe, H. Yoshida, Y. Banno, Y. Akao, M. Tanaka, and Y. Nozawa. 2003. Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J. Mol. Med. 81:126-131.
48. Zhao, Y., H. Ehara, Y. Akao, M. Shamoto, Y. Nakagawa, Y. Banno, T. Deguchi, N. Ohishi, K. Yagi, and Y. Nozawa. 2000. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem. Biophys. Res. Commun. 278:140-143.
49. Zhong, M., T. Joseph, D. Jackson, S. Beychenok, and D. A. Foster. 2002. Elevated phospholipase D induces apoptosis in normal rat fibroblasts. Biochem. Biophys. Res. Commun. 298:474-477.
50. Zhong, M., Y. Shen, Y. Zheng, T. Joseph, D. Jackson, S. Beychenok, and D. A. Foster. 2003. Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem. Biophys. Res. Commun. 302:615-619.
51. Zhu, T., L. Ling, and P. E. Lobie. 2002. Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent. J. Biol. Chem. 277:45592-45603.